Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis

Respiratory Care

Volumn 50, Issue 11, 2005, Pages 1438-1444

  Laube, Beth L ^a,e   Geller, David E ^b   Lin, Ta Chun ^a   Dalby, Richard N ^c   Diener West, Marie ^d   Zeitlin, Pamela L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aerosol; Cystic fibrosis; Nebulizer; Positive expiratory pressure

Indexed keywords

SODIUM CHLORIDE; TECHNETIUM 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AEROSOL; ARTICLE; BREATHING APPARATUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG DISTRIBUTION; FEMALE; HUMAN; HYPOTHESIS; LUNG CLEARANCE; LUNG DEPOSIT; MALE; NEBULIZATION; NEBULIZER; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY AIRFLOW; SCINTILLATION CAMERA; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; NONPARAMETRIC TEST; PARTICLE SIZE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; TISSUE DISTRIBUTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; CYSTIC FIBROSIS; FEMALE; GAMMA CAMERAS; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POSITIVE-PRESSURE RESPIRATION; RADIOPHARMACEUTICALS; RESPIRATORY FUNCTION TESTS; SODIUM CHLORIDE; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION;

EID: 33644841077     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Evans I, Hambleton G, Mann N, Brown J. The distribution of lung damage in children with cystic fibrosis and its relationship to colonisation with Pseudomonas aeruginosa. Eur J Nucl Med 1987;12(12):620-622.
2. 99mTc aerosol in normal subjects and in cystic fibrosis patients. Chest 1989;95(4):822-830.
3. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 1987;136(6):1445-1449.
4. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997;131(4):570-574.
5. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001;138(6):845-850.
6. ATS statement-Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979;119(5):831-838.
7. Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate. Chest 2000;118(4):1069-1076.
8. Macey DJ, Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J Nucl Med 1982;23(8):731-735.
9. Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 1998;101(4 Pt 1):475-483.
10. Laube BL, Benedict GW, Dobs AS. Time to peak insulin level, relative bioavailability and effect of site of deposition of nebulized insulin in patients with non-insulin dependent diabetes mellitus. J Aerosol Med 1998;11(3):153-173.
11. Laube BL, Swift DL, Wagner HN Jr, Norman PS, Adams GK 3rd. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. J Allergy Clin Immunol 1992;89(5):510-518.
12. Stolk J, Camps J, Feitsma HI, Hermans J, Dijkman JH, Pauwels EK. Pulmonary deposition and disappearance of aerosolized secretory leucocyte protease inhibitor. Thorax 1995;50(6):645-650.
13. Wilson D, Burniston M, Moya E, Parkin A, Smye S, Robinson P, Littlewood J. Improvement of nebulised antibiotic delivery in cystic fibrosis. Arch Dis Child 1999;80(4):348-352.